Search by Drug Name or NDC
NDC 70511-0101-50 SODIUM PHENYLACETATE AND SODIUM BENZOATE 100; 100 mg/mL; mg/mL Details
SODIUM PHENYLACETATE AND SODIUM BENZOATE 100; 100 mg/mL; mg/mL
SODIUM PHENYLACETATE AND SODIUM BENZOATE is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by MAIA PHARMACEUTICALS, INC. The primary component is SODIUM BENZOATE; SODIUM PHENYLACETATE.
Product Information
NDC | 70511-0101 |
---|---|
Product ID | 70511-101_c158c088-1ab5-4099-a174-96aba96feb11 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | SODIUM PHENYLACETATE AND SODIUM BENZOATE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | sodium phenylacetate and sodium benzoate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
Route | INTRAVENOUS |
Active Ingredient Strength | 100; 100 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | SODIUM BENZOATE; SODIUM PHENYLACETATE |
Labeler Name | MAIA PHARMACEUTICALS, INC |
Pharmaceutical Class | Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA208521 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70511-0101-50 (70511010150)
NDC Package Code | 70511-101-50 |
---|---|
Billing NDC | 70511010150 |
Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (70511-101-50) / 50 mL in 1 VIAL, SINGLE-DOSE |
Marketing Start Date | 2017-05-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |